<!DOCTYPE html>
<html lang="en">

<head>
  <meta charset="utf-8">
  <meta content="width=device-width, initial-scale=1.0" name="viewport">
  <title>Services - NYK BioSolutions</title>
  <meta name="description" content="">
  <meta name="keywords" content="">

  <!-- Favicons -->
  <!-- Favicons -->
  <link href="assets/img/squarelogo.png" rel="icon">
  <link href="assets/img/squarelogo.png" rel="apple-touch-icon">

  <!-- Fonts -->
  <link href="https://fonts.googleapis.com" rel="preconnect">
  <link href="https://fonts.gstatic.com" rel="preconnect" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Open+Sans:ital,wght@0,300;0,400;0,500;0,600;0,700;0,800;1,300;1,400;1,500;1,600;1,700;1,800&family=Poppins:ital,wght@0,100;0,200;0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,100;1,200;1,300;1,400;1,500;1,600;1,700;1,800;1,900&family=Jost:ital,wght@0,100;0,200;0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,100;1,200;1,300;1,400;1,500;1,600;1,700;1,800;1,900&display=swap" rel="stylesheet">

  <!-- Vendor CSS Files -->
  <link href="assets/vendor/bootstrap/css/bootstrap.min.css" rel="stylesheet">
  <link href="assets/vendor/bootstrap-icons/bootstrap-icons.css" rel="stylesheet">
  <link href="assets/vendor/aos/aos.css" rel="stylesheet">
  <link href="assets/vendor/glightbox/css/glightbox.min.css" rel="stylesheet">
  <link href="assets/vendor/swiper/swiper-bundle.min.css" rel="stylesheet">

  <!-- Main CSS File -->
  <link href="assets/css/main.css" rel="stylesheet">

  <!-- =======================================================
  * Template Name: Arsha
  * Template URL: https://bootstrapmade.com/arsha-free-bootstrap-html-template-corporate/
  * Updated: Aug 07 2024 with Bootstrap v5.3.3
  * Author: BootstrapMade.com
  * License: https://bootstrapmade.com/license/
  ======================================================== -->
</head>

<body class="starter-page-page">

  <header id="header" class="header d-flex align-items-center sticky-top">
    <div class="container-fluid container-xl position-relative d-flex align-items-center">

      <a href="index.html" class="logo d-flex align-items-center me-auto">
        <!-- Uncomment the line below if you also wish to use an image logo -->
        <img src="assets/img/squarelogo.png" alt="">
        <h1 class="sitename">NYK BioSolutions</h1>
      </a>

      <nav id="navmenu" class="navmenu">
        <ul>
          <li><a href="index.html">Home</a></li>
          <li><a href="About.html">About</a></li>
          <li><a href="Advisory.html">Advisory Board</a></li>
          <li><a href="Services.html" class="active">Services</a></li>
          <li><a href="Vision.html">Vision and Mission</a></li>
          
          <li><a href="Contact.html">Contact</a></li>
        </ul>
        <i class="mobile-nav-toggle d-xl-none bi bi-list"></i>
      </nav>

    </div>
  </header>

  <main class="main">

    <section id="toxicity" class="section why-us" data-builder="section">

      <!-- Section Title -->
      <div class="container section-title" data-aos="fade-up">
        <h2>Our Services</h2>
      </div><!-- End Section Title -->

      <div class="container-fluid">

        <div class="row gy-4">

          <div class="content px-xl-5" data-aos="fade-up" data-aos-delay="100">
            <h4 class="text-center"><span><Strong>Toxicity Studies</Strong></span></h4>
            <p class="text-center">
              These studies assess the safety profile of drugs, medical devices, and other substances by identifying potential adverse effects on biological systems. These evaluations ensure compliance with regulatory standards, enabling market approval
            </p>
          </div>

          <div class="col-lg-6 d-flex flex-column justify-content-center order-2 order-lg-1">
            <div class="faq-container px-xl-5" data-aos="fade-up" data-aos-delay="200">

              <div class="faq-item">
                <h3><span>01</span> Reproductive Toxicity</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>These studies are critical for regulatory toxicology, helping to identify risks of chemicals to human reproduction and development. They also guide regulatory decisions for safe human and environmental exposure limits.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>02</span> Acute Toxicity</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Acute toxicity studies are a cornerstone of toxicological research and chemical safety
                    evaluation. They are crucial for determining the initial safety profile of substances, guiding regulatory
                    decisions, and ensuring public and environmental health Acute Toxicity study determines the toxic
                    potential of a substance after a single exposure. and help to identifies the dose range that causes
                    harm or fatality, aiding in risk assessment. ITs a essential requirements for Regulatory Compliance for
                    drugs, medical devices, chemicals etc and help the authoritied to categories product as per GHS
                    Classification.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>03</span> Subacute Toxicity</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Determines the specific organs or systems
                    affected by repeated exposure to the test substance that helps to identify early signs of toxicity that
                    may not manifest after a single exposure. along with this the relationship between dose levels and
                    toxic effects, which is essential for risk assessment. Supports the establishment of safe exposure limits
                    for humans and the environment. Essentials regulatory requirements as per OECD and ISO Guidelines. Sub-acute toxicity studies are essential for understanding the safety profile of substances
                    following repeated exposure. They provide a foundation for regulatory safety evaluations, support the
                    development of safe products, and ensure compliance with international guidelines, ultimately
                    safeguarding human health and the environment.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>04</span> Allergic Toxicity</h3>
                <div class="faq-content">
                  <p>Reach out to us for more details.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>05</span> Ecotoxicology</h3>
                <div class="faq-content">
                  <p>Reach out to us for more details.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->
            </div>

          </div>

          <div class="col-lg-6 d-flex flex-column justify-content-center order-2 order-lg-1">
            <div class="faq-container px-xl-5" data-aos="fade-up" data-aos-delay="200">
              <div class="faq-item">
                <h3><span>06</span> Genetic Toxicology Testing</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Genotoxicity studies evaluate a substance's potential to damage the genetic material (DNA) in cells,
                    which can lead to mutations, chromosomal abnormalities, or cancer. These studies are essential for assessing chemical,
                    pharmaceutical, and environmental safety. Regulatory agencies worldwide require genotoxicity data to ensure the
                    safety of drugs, chemicals, cosmetics, and other products.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>07</span> Skin Irritation</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Skin irritation studies as per OECD guidelines play a crucial role in ensuring the safety of Industrial
                    chemicals,Pesticides. Drugs, cosmetics and products for human use. The guidelines provide scientifically validated
                    methods, emphasizing alternatives to animal testing wherever possible, thus balancing regulatory needs, human
                    safety, and ethical considerations.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>08</span> Compound Screening</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Is the process of testing chemical compounds or biologics to identify potential candidates
                    for treating specific diseases. It is a critical step in the drug discovery pipeline, aiming to identify compounds with
                    therapeutic potential before advancing them into preclinical and clinical development.
                    Following are the steps in Drug Compound Screening:
                    <br>
                    <br>
                    <strong>Compound Library Preparation:</strong> Large libraries of diverse chemical entities, including natural products, synthetic compounds, or biologics, are curated.
                    <br>
                    <strong>Assay Development:</strong> Design of sensitive and reliable assays (in vitro or in vivo) to measure activity against the target
                    or phenotype.
                    <br>
                    <strong>Primary Screening:</strong> Initial testing of the library to identify "hits" – compounds showing desired activity.
                    <br>
                    <strong>Secondary Screening:</strong> Validation of hits to confirm activity and eliminate false positives. Includes counter-screening
                    for off-target effects.
                    <br>
                    <strong>Preclinical Validation:</strong> Testing optimized compounds in disease models for efficacy, safety, and pharmacokinetics.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>09</span> Drug Toxicity</h3>
                <div class="faq-content">
                  <p>Reach out to us for more details.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>10</span> Chronic Toxicity</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Chronic toxicity studies are conducted to evaluate the long-term effects of repeated exposure to a
                    substance ( Drug, Chemicals , Pesticides, Cosmetics etc) over a significant portion of an organism's lifespan. These
                    studies are essential for assessing risks associated with prolonged human exposure to chemicals, pharmaceuticals, and
                    other products. The OECD guidelines provide a standardized framework for conducting chronic toxicity studies to
                    ensure reliability and regulatory compliance.
                    
                    These studies are indispensable for understanding the long-term safety of substances and are critical for regulatory
                    approval. The data generated provides a foundation for setting exposure limits and ensuring public health and
                    environmental safety. The OECD guidelines ensure that these studies are conducted consistently, ethically, and
                    scientifically.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->
            </div>

          </div>
        </div>

      </div>

    </section><!-- Toxicity Section -->
    <br>
    <br>
    <section id="rest" class="section why-us light-background" data-builder="section">
      <br>
      <br>
      <div class="container-fluid">

        <div class="row gy-4">

          <div class="col-lg-6 d-flex flex-column justify-content-center order-2 order-lg-1">
            <div class="content px-xl-5" data-aos="fade-up" data-aos-delay="100">
              <h4 class="text-center"><span><Strong>Medical Device Testing</Strong></span></h4>
              <p class="text-center">
                Comprehensive testing ensuring compliance, safety, and performance
              </p>
            </div>
            <div class="faq-container px-xl-5" data-aos="fade-up" data-aos-delay="200">

              <div class="faq-item">
                <h3><span>01</span> Chemical Characterization</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Chemical characterization studies are essential for evaluating the safety of medical devices
                    by identifying and quantifying the chemical substances they may release during use. These studies are guided by ISO
                    10993-18, which is part of the ISO 10993 series for the biological evaluation of medical devices. Chemical
                    characterization plays a critical role in assessing potential risks associated with materials and ensuring compliance with
                    regulatory requirements. These studies identify and mitigate risks, support biocompatibility assessments, and meet
                    regulatory expectations. This process not only protects patient safety but also facilitates global market access for
                    medical devices.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>02</span> Toxicological Risk Assessments</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Toxicological risk assessments (TRA) a critical process for evaluating the safety of
                    medical devices, particularly in terms of their materials, chemical constituents, and potential biological effects. It is an
                    essential part of regulatory compliance and is guided by international standards like ISO 10993-1, which outlines the
                    biological evaluation of medical devicesng in line with international regulatory standards. Its a cornerstone of medical
                    device safety evaluation. It ensures that devices are safe for their intended use, aligns with regulatory requirements,
                    and supports a risk-based approach to design and material selection. TRA helps manufacturers address safety concerns
                    proactively, fostering innovation while protecting patient health. By integrating TRA into the risk management process,
                    medical devices can achieve compliance and global market acceptance.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>03</span> International Regulatory Standards</h3>
                <div class="faq-content">
                  <p>Reach out to us for more details.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>04</span> Pyrogen Testing</h3>
                <div class="faq-content">
                  <p>Reach out to us for more details.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>05</span> Biocompatibility Studies</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Biocompatibility studies are essential for ensuring the safety of medical devices that come into direct or indirect contact with the human
                    body. The ISO 10993 series provides a comprehensive framework for evaluating the biological safety of medical devices. Each part of the
                    standard focuses on specific aspects of biocompatibility testing and risk assessment.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>06</span> Clinical Trials</h3>
                <div class="faq-content">
                  <p>Reach out to us for more details.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->
            </div>

          </div>

          <div class="col-lg-6 d-flex flex-column justify-content-center order-2 order-lg-1">
            <div class="content px-xl-5" data-aos="fade-up" data-aos-delay="100">
              <h4 class="text-center"><span><Strong><i>In Vitro</i> ADME Studies</Strong></span></h4>
              <p class="text-center">
                Reliable <i>in vitro</i> ADME studies for drug metabolism and pharmacokinetics
              </p>
            </div>
            <div class="faq-container px-xl-5" data-aos="fade-up" data-aos-delay="200">

              <div class="faq-item">
                <h3><span>01</span> Aqueous Solubility and Stability:</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Evaluation of compound
                    solubility and stability across different pH levels.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>02</span> Temperature Stability</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Assessment of compound stability under
                    various storage conditions, including ambient temperature, 2–8°
                    C, and –20°C.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>03</span> Biological Matrix Stability</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Investigation of short-term and
                    long-term stability of the compound in biological matrices such as
                    plasma or serum.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>04</span> Metabolic Stability</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Studies using cellular systems (e.g., hepatocytes from rat,
                    mouse, human, etc.) and subcellular fractions.
                    <br><br>
                    Metabolic stability assessment with recombinant CYP isoforms (e.g., CYP3A4, CYP2C9, CYP2C19, CYP2D6, CYP1A2).
                  </p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>05</span> Cell Permeability Assays</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Evaluation of compound permeability
                    using PAMPA, MDCK, and CaCo-2 models.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>06</span> Plasma/Serum Protein Binding</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Determination of protein binding
                    using ultrafiltration or equilibrium dialysis techniques.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->
            </div>

          </div>
        </div>

      </div>

    </section><!-- Toxicity Section -->
    <br>
    <br>
    <section id="toxicity" class="section why-us" data-builder="section">
      <div class="container-fluid">

        <div class="row gy-4">

          <div class="content px-xl-5" data-aos="fade-up" data-aos-delay="100">
            <h4 class="text-center"><span><Strong>Other Studies and Testings</Strong></span></h4>
            <p class="text-center">
            </p>
          </div>

          <div class="col-lg-6 d-flex flex-column justify-content-center order-2 order-lg-1">
            <div class="faq-container px-xl-5" data-aos="fade-up" data-aos-delay="200">

              <div class="faq-item">
                <h3><span>01</span> Drug discovery support services</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Reach out to us for more details.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>02</span> Preclinical studies (<i>in vitro & in vivo</i>)</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Reach out to us for more details.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>03</span> Preclinical immunogenicity</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Reach out to us for more details.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>04</span> Patent Application support</h3>
                <div class="faq-content">
                  <p>Reach out to us for more details.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>05</span> Cosmetics testing (<i>in vitro</i>)</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Cosmetics testing (<i>in vitro</i>)
                    and proof of concept
                    studies to support patent
                    grant</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>06</span> R&D based customised services</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>R&D based customised services
                    based on proposal. Reach out to us for more details.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->
            </div>

          </div>

          <div class="col-lg-6 d-flex flex-column justify-content-center order-2 order-lg-1">
            <div class="faq-container px-xl-5" data-aos="fade-up" data-aos-delay="200">

              <div class="faq-item">
                <h3><span>07</span> Cell line characterisation and genetic stability studies</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Cell line characterisation and genetic
                    stability studies in MCB, WCB and EoP
                    cells as per ICHQ 5 guidelines.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>08</span> Cell based assays <i>in vitro</i></h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>In-vitro immunogenicity using PBMCs
                    <br>
                    <br>
                    Toxicity and efficacy studies on <i>in vitro</i> disease models of cancer, Diabetes, Inflammation, Pulmonary disease, Psoriasis and Osteoporosis.
                    <br>
                    <br>
                    Flow Cytometry Assays
                    <br>
                    <br>
                    Gene expression Assays
                  </p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>09</span> In vivo disease models for preclinical studies</h3>
                <div class="faq-content">
                  <p>Reach out to us for more details.</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>10</span> Oncology</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Syngeneic and xenograft models</p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>11</span> Respiratory diseases</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>Asthma Model
                    <br>
                    <br>
                    Lung Inflammation and Fibrosis Model
                    <br>
                    <br>
                    Chronic Obstructive Pulmonary Disease (COPD) Model
                  </p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->

              <div class="faq-item">
                <h3><span>12</span> <i>In Vivo</i> DMPK</h3>
                <div class="faq-content" style="text-align: justify;">
                  <p>
                    Absolute Bioavailability Studies
                    <br>
                    <br>
                    PK/PD Studies (Pharmacokinetics/Pharmacodynamics)
                  </p>
                </div>
                <i class="faq-toggle bi bi-chevron-right"></i>
              </div><!-- End Faq item-->
            </div>

          </div>
        </div>

      </div>

    </section><!-- Toxicity Section -->

  </main>

  <footer id="footer" class="footer" style="color: #000000;">

    <div class="container copyright text-center mt-4">
      <p>© <span>Copyright</span> <strong class="px-1 sitename">NYK BioSolutions</strong> <span>All Rights Reserved</span></p>
      <div class="credits">
        <!-- All the links in the footer should remain intact. -->
        <!-- You can delete the links only if you've purchased the pro version. -->
        <!-- Licensing information: https://bootstrapmade.com/license/ -->
        <!-- Purchase the pro version with working PHP/AJAX contact form: [buy-url] -->
        Designed by <a href="https://bootstrapmade.com/">BootstrapMade</a>
      </div>
    </div>

  </footer>

  <!-- Scroll Top -->
  <a href="#" id="scroll-top" class="scroll-top d-flex align-items-center justify-content-center"><i class="bi bi-arrow-up-short"></i></a>

  <!-- Preloader -->
  <div id="preloader"></div>

  <!-- Vendor JS Files -->
  <script src="assets/vendor/bootstrap/js/bootstrap.bundle.min.js"></script>
  <script src="assets/vendor/php-email-form/validate.js"></script>
  <script src="assets/vendor/aos/aos.js"></script>
  <script src="assets/vendor/glightbox/js/glightbox.min.js"></script>
  <script src="assets/vendor/swiper/swiper-bundle.min.js"></script>
  <script src="assets/vendor/waypoints/noframework.waypoints.js"></script>
  <script src="assets/vendor/imagesloaded/imagesloaded.pkgd.min.js"></script>
  <script src="assets/vendor/isotope-layout/isotope.pkgd.min.js"></script>

  <!-- Main JS File -->
  <script src="assets/js/main.js"></script>

</body>

</html>